Oxytocin is a peptide hormone studied in several settings, including social behaviour. Calling it a bonding hormone does not establish that a product improves relationships or treats social difficulties.
What the research shows
A 2021 randomized trial in 290 autistic children and adolescents found no significant advantage over placebo on its principal social or cognitive outcomes. A 2023 trial in 77 children also found no specific improvement in the primary social-responsiveness measure. Exploratory subgroup findings do not establish general benefits. [1] [2]
Distinguishing substances and products
The hormone's role in the body is distinct from a product's evidence. Formulation and intended use need separate assessment. Natural-hormone terminology does not establish product safety.
Reading a specific brand’s label
Start with the exact substance and product name, then match the label to the manufacturer’s documents. This article does not establish Thai registration or current availability for an unspecified product.
Frequently asked questions
Do these trials establish benefits for autistic social difficulties?
No. The cited trials did not show a placebo advantage on the principal measures described.
Does the bonding-hormone label validate a product claim?
No. Evidence must match the formulation and claimed outcome.
What information helps identify a specific product?
The brand, product name, full label and matching manufacturer documents. Evidence about the substance alone does not establish a product’s identity, registration or quality.
Related information
For general questions about names or label details, contact LINE: @musclestationth
Sources and review date
Sources checked: 11 September 2026. This page explains selected primary sources; it is not a systematic review of every study.